The FINANCIAL — Johnson & Johnson announced million in commitments and collaborations over the next five years to invest in and promote health equity solutions for Black people and other communities of color in the United States. Society has been significantly impacted
More
The FINANCIAL — Gartner, Inc. has announced the winners of the 2020 Gartner Eye on Innovation Award for healthcare and life sciences. The award recognizes innovative use of technology-enabled capabilities in three areas: technology innovation with a health outcome; technology innovation with
More
The FINANCIAL — The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, continues to enroll and vaccinate study participants. ENSEMBLE
More
The FINANCIAL — Global pharmaceutical company Janssen will begin clinical trials of its potential vaccine in the UK from today (Monday 16 November), involving 6,000 volunteers across the country. The Janssen Pharmaceutical Companies, part of Johnson & Johnson, is the latest study
More
The FINANCIAL — Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million
More